Literature DB >> 10200932

In vitro susceptibility of Candida species to lactoferrin.

Y Y Xu1, Y H Samaranayake, L P Samaranayake, H Nikawa.   

Abstract

Lactoferrin is an antimicrobial protein present in human mucosal secretions as well as saliva. As there is no information on the relative fungicidal activity of human and bovine lactoferrin, an oral isolate of Candida albicans was studied for its susceptibility to these two proteins. Exposure to a concentration of 20 micrograms ml-1 of either HLF or BLF at 37 degrees C inactivated the yeast to the same degree irrespective of the incubation time of 45, 90 or 150 min. A similar study, using 20 micrograms ml-1 BLF and an incubation time of 150 min, elicited varying anticandidal activity against 35 isolates belonging to six different Candida species. Thus, BLF was fungicidal for the six Candida species in the following decreasing order, C. tropicalis > C. krusei > C. albicans > C. guilliermondii > C. parapsilosis > C. glabrata; the latter being the most resistant. These Candida species also demonstrated significant intra-species variation in susceptibility to the protein (P < 0.05). When the yeast cells exposed to BLF were examined by cryo-scanning electron microscopy, profound cell wall changes such as cell surface blebs, swelling and cell collapse were noted. These findings suggest that lactoferrin, a constituent of saliva, may differentially modulate the carriage of Candida species in the oral cavity.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10200932     DOI: 10.1046/j.1365-280x.1999.00198.x

Source DB:  PubMed          Journal:  Med Mycol        ISSN: 1369-3786            Impact factor:   4.076


  19 in total

Review 1.  Beyond Candida albicans: Mechanisms of immunity to non-albicans Candida species.

Authors:  Natasha Whibley; Sarah L Gaffen
Journal:  Cytokine       Date:  2015-08-11       Impact factor: 3.861

2.  Antifungal effects of lysozyme and lactoferrin against genetically similar, sequential Candida albicans isolates from a human immunodeficiency virus-infected southern Chinese cohort.

Authors:  Y H Samaranayake; L P Samaranayake; E H Pow; V T Beena; K W Yeung
Journal:  J Clin Microbiol       Date:  2001-09       Impact factor: 5.948

3.  Regulation of fungal infection by a combination of amphotericin B and peptide 2, a lactoferrin peptide that activates neutrophils.

Authors:  Tetsuro Okamoto; Toyohiro Tanida; Benjuan Wei; Eisaku Ueta; Tetsuya Yamamoto; Tokio Osaki
Journal:  Clin Diagn Lab Immunol       Date:  2004-11

4.  Lactoferrin peptide increases the survival of Candida albicans-inoculated mice by upregulating neutrophil and macrophage functions, especially in combination with amphotericin B and granulocyte-macrophage colony-stimulating factor.

Authors:  T Tanida; F Rao; T Hamada; E Ueta; T Osaki
Journal:  Infect Immun       Date:  2001-06       Impact factor: 3.441

Review 5.  The impact of metal availability on immune function during infection.

Authors:  Andrew J Monteith; Eric P Skaar
Journal:  Trends Endocrinol Metab       Date:  2021-09-03       Impact factor: 12.015

Review 6.  Lactoferrin as a natural immune modulator.

Authors:  Jeffrey K Actor; Shen-An Hwang; Marian L Kruzel
Journal:  Curr Pharm Des       Date:  2009       Impact factor: 3.116

7.  Oral lactoferrin treatment of experimental oral candidiasis in mice.

Authors:  Natsuko Takakura; Hiroyuki Wakabayashi; Hiroko Ishibashi; Susumu Teraguchi; Yoshitaka Tamura; Hideyo Yamaguchi; Shigeru Abe
Journal:  Antimicrob Agents Chemother       Date:  2003-08       Impact factor: 5.191

8.  Detecting Candida albicans in human milk.

Authors:  Jimi Francis Morrill; Demosthenes Pappagianis; M Jane Heinig; Bo Lönnerdal; Kathryn G Dewey
Journal:  J Clin Microbiol       Date:  2003-01       Impact factor: 5.948

9.  Modulation of in vitro fungicidal activity of human lactoferrin against Candida albicans by extracellular cation concentration and target cell metabolic activity.

Authors:  Mónica Viejo-Díaz; María T Andrés; José F Fierro
Journal:  Antimicrob Agents Chemother       Date:  2004-04       Impact factor: 5.191

10.  In Vivo Efficacy of Lacticaseibacillus rhamnosus L8020 in a Mouse Model of Oral Candidiasis.

Authors:  Rei Ito; Yuichi Mine; Yoshie Yumisashi; Reina Yoshioka; Misa Hamaoka; Tsuyoshi Taji; Takeshi Murayama; Hiroki Nikawa
Journal:  J Fungi (Basel)       Date:  2021-04-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.